Timing of Apixaban Resumption After Surgery
Resume apixaban 24 hours after low-bleeding-risk surgery or 48-72 hours after high-bleeding-risk surgery, once adequate hemostasis is established. 1, 2
Surgical Bleeding Risk Stratification
The timing of apixaban resumption depends critically on the bleeding risk of your procedure:
Low-to-Moderate Bleeding Risk Surgery
- Resume at 24 hours postoperatively at full dose (5 mg twice daily) 1
- Examples: most laparoscopic procedures, minor orthopedic surgery, dental procedures
- Ensure adequate wound hemostasis before restarting
High Bleeding Risk Surgery
- Resume at 48-72 hours postoperatively at full dose (5 mg twice daily) 1
- Examples: major abdominal surgery, neurosurgery, spinal procedures, major orthopedic surgery
- For patients at very high thrombotic risk, consider reduced-dose apixaban (2.5 mg twice daily) starting earlier, then escalate to full dose after 2-3 days 1
Special Considerations for High Thrombotic Risk Patients
If your patient has high thrombotic risk (mechanical heart valve, recent VTE, high CHADS₂ score ≥5):
- Consider bridging with prophylactic-dose LMWH (enoxaparin 40 mg daily) starting 6-24 hours postoperatively 3, 4
- Transition to reduced-dose apixaban (2.5 mg twice daily) at 48 hours, then full dose at 72 hours 1
- Do not use therapeutic-dose bridging - this significantly increases bleeding risk without proven benefit 3
Duration of Extended Prophylaxis
The question of "how long" has two interpretations:
For Patients on Chronic Anticoagulation (Atrial Fibrillation, Prior VTE)
- Resume apixaban as outlined above and continue indefinitely based on the underlying indication 2
- The FDA label specifies continuing apixaban for stroke prevention in AF or VTE treatment as long as the indication persists 2
For Surgical VTE Prophylaxis Only
- 12 days for knee replacement surgery 2
- 35 days for hip replacement surgery 2
- 28-30 days for major abdominal/pelvic cancer surgery 4, 5, 6
- Recent evidence supports 14-30 day prophylaxis for bariatric surgery with excellent safety profiles 7, 8, 9
Critical Timing Details
Apixaban has rapid onset (peak effect 1-3 hours) 1, making it similar to therapeutic-dose LMWH. This is why cautious, delayed resumption is essential after high-bleeding-risk procedures.
Common Pitfalls to Avoid:
- Never resume full-dose apixaban immediately postoperatively - the rapid anticoagulant effect increases bleeding risk 1
- Avoid neuraxial anesthesia/procedures if apixaban was recently taken - ensure at least 48-72 hours have elapsed since last dose 4
- Do not double-dose if a dose is missed - simply resume the regular schedule 2
- Bowel surgery patients may have delayed absorption - this typically resolves within 24-72 hours and is not clinically significant 1
Practical Algorithm
- Assess surgical bleeding risk (low vs. high)
- Confirm adequate hemostasis at surgical site
- Low-risk surgery: Resume apixaban 5 mg twice daily at 24 hours
- High-risk surgery: Resume apixaban 5 mg twice daily at 48-72 hours
- Very high thrombotic risk + high bleeding risk: Consider prophylactic LMWH bridge, then reduced-dose apixaban (2.5 mg twice daily) at 48 hours, escalating to full dose at 72 hours
- Continue duration based on indication (indefinite for AF/VTE, or procedure-specific prophylaxis duration)
The 2012 Blood guidelines 1 and 2017 French GIHP guidelines 4 provide the most comprehensive framework, while the 2022 CHEST guidelines 10 and FDA label 2 confirm these recommendations remain current standard of care.